CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency

Molecular and Cellular Biochemistry

Volumn 192, Issue 1-2, 1999, Pages 129-135

  Nozaki, Shuichi ^a   Tanaka, Takao ^b   Yamashita, Shizuya ^a   Sohmiya, Koichi ^a   Yoshizumi, Tohru ^c   Okamoto, Fumio ^b   Kitaura, Yasushi ^b   Kotake, Chikao ^d   Nishida, Hiroyuki ^d   Nakata, Atsuyuki ^a   Nakagawa, Tsutomu ^a   Matsumoto, Kengo ^a   Kameda Takemura, Kaoru ^a   Tadokoro, Seiji ^a   Kurata, Yoshiyuki ^e   Tomiyama, Yoshiaki ^a   Kawamura, Keishiro ^b   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c Minoo City Hospital   (Japan)

^d SAISEIKAI NAKATSU HOSPITAL   (Japan)

^e OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

CD36 deficiency; Mutation of CD36 gene; Myocardial long chain fatty acid uptake

Indexed keywords

CD36 ANTIGEN; FATTY ACID DERIVATIVE; IODINE 123; LONG CHAIN FATTY ACID;

ADULT; ANTIGEN EXPRESSION; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; DELETION MUTANT; FATTY ACID TRANSPORT; FEMALE; GENE EXPRESSION; GENETIC DISORDER; HEART MUSCLE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MONOCYTE; POINT MUTATION; RESTRICTION MAPPING; THROMBOCYTE;

BOVINAE;

EID: 0032907123     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-4929-1_15     Document Type: Conference Paper

References (38)

1. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grialdi PA: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665-17668, 1993
2. Tanaka T, Kawamura K: Isolation of myocardial membrane long-chain fatty acid-binding protein; homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids. J Mol Cell Cardiol 27: 1613-1622, 1995
3. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA: Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction and transfusion medicine. Blood 80: 1105-1115, 1992
4. Tandon NN, Kralisz NU, Jamieson GA: Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264: 7576-7583, 1989
5. Asch AS, Barnwell J, Silverstein RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest 79: 1054-1061, 1987
6. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816, 1993
7. a involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 57: 213-217, 1989
8. a, on platelet membrane glycoprotein IV. Blood 75: 684-687, 1990.
9. Kashiwagi H, Honda S, Tomiyama Y, Mizutani H, Take H, Honda Y, Kosugi S, Kanayama Y, Kurata Y, Matsuzawa Y: A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV. Thromb Haemostas 69: 481-484, 1993
10. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Kanayama Y, Kurata Y, Matsuzawa Y: Identification of molecular defects in a subject with type I CD36 deficiency. Blood 83: 3545-3552, 1994
11. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanayama Y, Kurata Y, Matsuzawa Y: Molecular basis of CD36 deficiency; evidence that a 478C-T substitution (proline90-serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 95: 1040-1046, 1995
12. Kashiwagi H, Tomiyama Y, Nozaki S, Honda S, Kosugi S, Shiraga M, Nakagawa T, Nagao N, Kanakura Y, Kurata Y, Matstizawa Y: A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb Vasc Biol 16: 1026-1032, 1996
13. a negative subjects whose platelets lack GPIV. Brit J Haematol 84: 387-391, 1993
14. Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K: Platelet glycoprotein IV (CD36) deficiency is associated with the absence (Type I) or the presence (Type II) of glycoprotein IV on monocytes. Blood 83: 392-397, 1994
15. Knapp Mr, Kropp J: Iodine-123-labeled fatty acids for myocardial single photonemission tomography: Current status and future perspectives. Eur J Nucl Med 22: 361-381, 1995
16. Knapp Mr, Franken P, Kropp J: Cardiac SPECT with iodine-123-labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 36: 1022-1030, 1995
17. Tateno M, Tamaki N, Yukihiro M, Kudoh T, Hattori N, Tadamura E, Nohara-R, Suzuki T, Endo K, Konishi J: Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 37: 1981-1985, 1996
18. 123I-BMIPP in patients with hypertrophic cardiomyopathy: Assessment by radial long-axis SPET. Nucl Med Commun 16: 336-343, 1995
19. Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M: Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP). Nucl Med Commun 15: 441-447, 1994
20. Hwang EHH, Yamashita A, Takemori H, et al.: Absent myocardial I-123 BMIPP uptake in a family. Ann Nucl Med 10: 445-448, 1996
21. Kudoh T, Tamaki N, Magata Y, Konishi J, Nohara R, Iwasaki A, Ono S, Ohtake Y, Sugihara H, Kuze K, Tsujimura Y, Miyazaki T: Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP. J Nucl Med 38: 548-553, 1997
22. Tanaka T, Sohmiya K, Kawamura K: Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29: 121-127, 1997
23. Van der Vusse GJ, Glatz JFC, Starn HCG, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72: 881-940, 1992
24. Rodrigues B, Cam MC, McNeffi JH: Myocardial substrate metabolism; implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169-179, 1995
25. DeGrella RF, Light RJ: Uptake and metabolism of fatty acids by dispersed adult rat heart myocytes. II. Inhibition by albumin and fatty acid homologues, and the effect of temperature and metabolic reagents. J Biol Chem 255: 9739-9745, 1980
26. Rose H, Hennecke T, Kammermeier H: Sarcolemmal fatty acid transfer in isolated cardiomyocytes governed by albumin/membrane-lipid partition. J Mol Cell Cardiol 22: 833-892, 1990
27. Harmon CM, Luce P, Beth AH, Abumrad NA: Labeling of adipocyte membranes by sulfo-N-succinimidyl derivates of long-chain fatty acids: Inhibition of fatty acid transporter. J Membrane Biol 121: 261-268, 1991
28. Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD: Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci USA 82: 4-8, 1985
29. Stremmel W, Lotz G, Strohmeyer G, Berk PD: Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest 75: 1068-1076, 1985
30. Stremmel W: Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport system. J Clin Invest 81: 844-853, 1988
31. Fujii S, Kawaguchi H, Yasuda H: Purification of high affinity fatty acid receptors in rat myocardial sarcolemmal membranes. Lipids 22: 544-546, 1987
32. Schaffer JE, Lodish HF: Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79: 427-436, 1994
33. Harmon CM, Aburnrad NA: Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and amino-terminal sequence of an 88-M protein implicated in transport of long-chain fatty acids. J Mem Biol 133: 43-49, 1993
34. Abumrad NA, Park JH, Park CR: Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J Biol Chem 259: 8945-8953, 1984
35. Kurata C, Kobayashi A, Yamazaki N: Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 30: 80-87, 1989
36. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H: Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 19: 775-782, 1992
37. Kusaka Y, Tanaka T, Okamoto F, Terasaki F, Matsunaga Y, Miyazaki H, Kawamura K: Effect of sulfo-N-succinimidyl palmitate on the rat heart: Myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol 27: 1605-1612, 1995
38. Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M, Koizumi T, Nikaido H, Hayakawa J, Kuwajima, M, Saheki T: Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 326: 267-271, 1993